Strong Antitumor Activity of Bevacizumab and Aflibercept in Neuroendocrine Carcinomas: In-Depth Preclinical Study.
Rodríguez-Remírez M, Del Puerto-Nevado L, Fernández Aceñero MJ, Ebrahimi-Nik H, Cruz-Ramos M, García-García L, Solanes S, Baños N, Molina-Roldán E, García-Foncillas J, Cebrián A.
Rodríguez-Remírez M, et al. Among authors: molina roldan e.
Neuroendocrinology. 2020;110(1-2):50-62. doi: 10.1159/000500591. Epub 2019 Apr 29.
Neuroendocrinology. 2020.
PMID: 31030198